2023-07-03 23:50:09
translation exclusiveThe British Medicines Agency has approved diocravacatinib for the treatment of the itchy skin condition psoriasis.
According to the British Daily Mail, a pill called diocravacatinib has been assigned to patients with moderate to severe forms of psoriasis.
And diocravacitinib has been shown in clinical trials to clear up regarding three-quarters of psoriatic rashes from the body, with diocravacatinib being the first oral treatment approved for the condition in nearly a decade.
The researchers found it to be safer than JAK inhibitors and more effective than current oral treatments offered on the NHS.
Experts said diocravacatinib would improve the lives of thousands of people in the UK.
Psoriasis is reported to cause red, scaly, itchy patches of skin, and in its most severe form can cover almost the entire body, with many sufferers itching to the point of bleeding.
1688434203
#British #Medicines #Authority #drug #succeeded #treating #psoriasis
